Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Clinical Trial
NCT05767346Last updated: 1/2/2026
Heart Failure
Heart Failure With Reduced Ejection Fraction
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Heart Failure